ArticleOphthalmology science

Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial.

Mark R Barakat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.